IP Library Granted Patent US 7,528,202
Granted Patent B2
US 7,528,202 · App. 11/799,259 · Granted May 5, 2009

Poly (ethylene glycol) derivatives with proximal reactive groups

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,528,202
App. No.
11/799,259
Granted
May 5, 2009
Kind
B2
Abstract

An activated, substantially water-soluble poly(ethylene glycol) is provided having of a linear or branched poly(ethylene glycol) backbone and at least one terminus linked to the backbone through a hydrolytically stable linkage, wherein the terminus is branched and has proximal reactive groups. The free reactive groups are capable of reacting with active moieties in a biologically active agent such as a protein or peptide thus forming conjugates between the activated (polyethylene glycol) and the biologically active agent.

Claims (24)

1. A water-soluble polymer comprising:

a branched polymer backbone having at least one terminus bonded to a branching atom through a hydrolytically stable linkage, the branching atom being covalently bonded to at least two reactive groups, each reactive group comprising a reactive moiety, wherein the branched polymer backbone comprises methoxy poly(ethylene glycol) disubstituted lysine.

2. The polymer of claim 1 , wherein the branching atom is a carbon atom.

3. The polymer of claim 1 , wherein said terminus of the backbone is bonded to the structure:

wherein Y is a hydrolytically stable linkage, A is a branching atom, and X and X′, which may be the same or different, are reactive groups comprising a reactive moiety.

4. The polymer of claim 3 , wherein A is CH.

5. The polymer of claim 4 , wherein at least one of said X and X′ has the structure —W-Z, wherein W is a tethering group and Z is said reactive moiety.

6. The polymer of claim 5 , wherein W is selected from the group consisting of alkyl chains, ether chains, ester chains, amide chains, and combinations thereof.

7. The polymer of claim 5 , wherein W is selected from the group consisting of —(CH 2 ) m —, —(CH 2 ) m —O—, —O—(CH 2 ) m —, —(CH 2 ) m —O 2 C—CH 2 CH 2 —, and —(CH 2 ) m —O—(CH 2 ) r —, wherein m and r are independently 1-10.

8. The polymer of claim 5 , wherein Z is selected from the group consisting of active esters, active carbonates, aldehydes, isocyanates, isothiocyanates, epoxides, alcohols, maleimides, vinylsulfones, hydrazides, dithiopyridines, and iodoacetainides.

9. The polymer of claim 5 , wherein Z is selected from the group consisting of —OH, —CO 2 H, —CHO, —SO 2 —CH═CH 2 , and —CO 2 -Q, wherein Q is N-succinimidyl, sulfo-N-succinimidyl, or 1-benzotriazolyl.

10. The polymer of claim 1 , wherein said reactive moiety is selected from the group consisting of active esters, active carbonates, aldehydes, isocyanates, isothiocyanates, epoxides, alcohols, maleimides, vinylsulfones, hydrazides, dithiopyridines, and iodoacetamides.

11. The polymer of claim 1 , wherein said reactive moiety is selected from the group consisting of —OH, —CO 2 H, —CHO, —SO 2 —CH═CH 2 , and —CO 2 -Q, wherein Q is N-succinimidyl, sulfo-N-succinimidyl, or 1-benzotriazolyl.

12. The polymer of claim 1 , wherein said branched polymer backbone has a molecular weight of about 100 to about 100,000 Da.

13. The polymer of claim 12 , wherein said branched polymer backbone has a molecular weight of about 6,000 to about 80,000 Da.

14. The polymer of claim 1 , wherein said branched polymer backbone is a poly(alkylene oxide) selected from the group consisting of poly(ethylene glycol), poly(propylene glycol), and copolymers of ethylene glycol and propylene glycol.

15. The polymer of claim 1 , wherein said branched polymer backbone is poly(ethylene glycol) having a molecular weight of about 200 to about 100,000 Da.

16. The polymer of claim 1 , wherein the hydrolytically stable linkage is selected from the group consisting of —O—, —S— and —CO—NH—.

17. The polymer of claim 1 , wherein the at least two reactive groups have the structure —W-Z and —W′-Z′, respectively, wherein Z and Z′ are said reactive moieties, and W and W′ are tethering groups.

18. The polymer of claim 17 , wherein W and W′ are selected from the group consisting of alkyl chains, ether chains, ester chains, amide chains, and combinations thereof.

19. The polymer of claim 17 , wherein W and W′ are independently selected from the group consisting of —(CH 2 ) m —, —(CH 2 ) m —O—, —O—(CH 2 ) m —, —(CH 2 ) m —O 2 C—CH 2 CH 2 —, and —(CH 2 ) m —O—(CH 2 ) r —, wherein m and r are independently 1-10.

20. The polymer of claim 17 , wherein Z and Z′ are each independently selected from the group consisting of active esters, active carbonates, aldehydes, isocyanates, isothiocyanates, epoxides, alcohols, maleimides, vinylsulfones, hydrazides, dithiopyridines, and iodoacetamides.

21. The polymer of claim 17 , wherein Z and Z′ are each independently selected from the group consisting of —OH, —CO 2 H, —CHO, —SO 2 —CH═CH 2 , and —CO 2 -Q, wherein Q is N-succinimidyl, sulfo-N-succinimidyl, or 1-benzotriazolyl.

22. The polymer of claim 1 , wherein each of the at least two reactive groups is maleimide.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →